company background image
688278 logo

Xiamen Amoytop Biotech SHSE:688278 Stock Report

Last Price

CN¥77.33

Market Cap

CN¥32.1b

7D

-5.9%

1Y

78.8%

Updated

31 Oct, 2024

Data

Company Financials +

Xiamen Amoytop Biotech Co., Ltd.

SHSE:688278 Stock Report

Market Cap: CN¥32.1b

688278 Stock Overview

Engages in the manufacture, marketing, and sale of recombinant protein drugs in China.

688278 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth6/6
Past Performance5/6
Financial Health6/6
Dividends1/6

Xiamen Amoytop Biotech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Xiamen Amoytop Biotech
Historical stock prices
Current Share PriceCN¥77.33
52 Week HighCN¥86.11
52 Week LowCN¥41.85
Beta0.45
11 Month Change7.93%
3 Month Change57.49%
1 Year Change78.84%
33 Year Change168.69%
5 Year Changen/a
Change since IPO119.07%

Recent News & Updates

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Sep 19
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Sep 19
Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Recent updates

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Sep 19
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Sep 19
Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?

Jun 12
Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?

Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 04
Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk

Mar 25
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk

Shareholder Returns

688278CN BiotechsCN Market
7D-5.9%-1.7%0.1%
1Y78.8%-16.9%4.1%

Return vs Industry: 688278 exceeded the CN Biotechs industry which returned -16.9% over the past year.

Return vs Market: 688278 exceeded the CN Market which returned 4.1% over the past year.

Price Volatility

Is 688278's price volatile compared to industry and market?
688278 volatility
688278 Average Weekly Movement9.3%
Biotechs Industry Average Movement9.0%
Market Average Movement7.8%
10% most volatile stocks in CN Market11.7%
10% least volatile stocks in CN Market5.3%

Stable Share Price: 688278 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 688278's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19962,106Li Sunwww.amoytop.com

Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China. It provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. The company was founded in 1996 and is based in Xiamen, China.

Xiamen Amoytop Biotech Co., Ltd. Fundamentals Summary

How do Xiamen Amoytop Biotech's earnings and revenue compare to its market cap?
688278 fundamental statistics
Market capCN¥32.07b
Earnings (TTM)CN¥740.69m
Revenue (TTM)CN¥2.60b

42.5x

P/E Ratio

12.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688278 income statement (TTM)
RevenueCN¥2.60b
Cost of RevenueCN¥179.47m
Gross ProfitCN¥2.42b
Other ExpensesCN¥1.68b
EarningsCN¥740.69m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.82
Gross Margin93.08%
Net Profit Margin28.54%
Debt/Equity Ratio0%

How did 688278 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

23%

Payout Ratio